Overview

Lurasidone Pediatric Bipolar Study

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
A study to evaluate efficacy and safety of flexibly dosed Lurasidone in children and adolescents with bipolar I depression
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride